No Data
No Data
Express News | Kezar Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Express News | Kezar Life Sciences is eligible to receive an additional 180 days or until November 25th to meet the Nasdaq minimum bid price requirement.
Express News | Kezar Life Sciences received a letter from NASDAQ on May 31 confirming approval of the company's transfer application to the NASDAQ capital markets.
Express News | Kezar Life Sciences-Eligible for Additional 180 Calendar Day Period, or Until Nov 25 to Regain Compliance With Nasdaq Minimum Bid Price Requirement
Express News | Kezar Life Sciences Inc -Notified by Nasdaq in Letter Dated May 31, Co’s Application to Transfer to Nasdaq Capital Market Was Approved
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference